- NORTH AMERICA EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Aphria Rumored to Court Deal with Marlboro Producer
A new report indicates the company behind Marlboro cigarettes is looking at a deal for a stake in a Canadian cannabis company.
Tobacco leading corporation and Fortune 500 company Altria Group (NYSE:MO) is eyeing a stake in a Canadian cannabis producer, according to a new report.
On Wednesday (October 10), The Globe and Mail reported the parent company of Philip Morris USA, maker of Marlboro cigarettes, was in a position to buy a portion of Aphria (TSX:APH).
The report indicated the deal is not in the final stages and could still take some time to finalize. The proposition could also be scrapped at this time, according to the reporting.
Aphria issued a statement on Wednesday claiming no deal is finalized yet.
While Aphria engages in discussions with potential strategic partners and/or investors from time to time, the Company notes that there is no agreement, understanding or arrangement in place with a potential investor at this time.
Altria Group is a company with over US$100 billion in valuation, with additional assets like Ste. Michelle Wine Estates and a substantial share of control for alcohol producer Anheuser-Busch InBev (NYSE:BUD). Aphria has grown to reach nearly a C$5 billion market capitalization.
Difficult optics for tobacco entry, says financial expert
As the cannabis market continues its expansion thanks to the legalization worldwide trend, major companies from established markets have started to make bets into cannabis.
Doug Waterson, CFO and portfolio manager with Faircourt Asset Management and manager of the Ninepoint UIT Alternative Health Fund, told the Investing News Network he had expected tobacco’s play in to cannabis to take longer than alcohol or pharmaceuticals.
“Tobacco you would think … they have their own baggage obviously to deal with,” Waterson said. “I would say it’s more important to them to do a deal but it’s also probably more difficult just politically, [with] shareholders, everything. It’s a challenging thing.”
Investor takeaway
Shares of Aphria jumped after the report went live and closed the day with a 16.29 percent spike and finishing with a price tag of C$20.06.
On Thursday the stock balanced with a minor drop at the start of the trading session. As of 12:37 EST, APH is valued at C$20.12, representing a 0.55 percent increase.
Shares of the tobacco company dropped following the revelation of its talks with Aphria. The stock reached a week high of US$64 before it started falling, finishing the day at a price of US$62.92.
As of 12:30 p.m. EST on Thursday, MO was down 1.19 percent, representing a loss of US$0.75, for a share price of US$61.93.
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.